NewGenIvf Group Ltd Dossier
|
SectorHealth Care IndustryHealth Care Facilities Beta (adjusted)0.31 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $0.10Price as of 1 Oct 2026 Data confidence Sign in to view data confidence Market Cap $281.8K Enterprise Value $4.4M Shares Outstanding 2.1M diluted Moat Rating None All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary NewGenIvf Group Ltd (NIVF) is undergoing a rapid and highly speculative strategic pivot. Historically focused on assisted reproductive services in Asia, the company has aggressively diversified into digital assets, UAE real estate, and AI-driven prediction platforms (notably its 10% stake in K25.ai). While FY 2025 results showed a massive surge in total assets to US$32.7 million and a net profit of US$9.9 million, these gains were primarily driven by non-operational bargain purchase gains from acquisitions. The core business remains highly volatile, and the aggressive expansion into high-risk sectors like Web3 and AI-native livestreaming warrants a cautious 'Hold' stance until sustainable operational cash flows materialize. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$42.36 Mean target$42.36 High · most bullish analyst$42.36 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $0.2520% The bear case is triggered by severe regulatory crackdowns on digital assets or prediction markets in APAC, failure of K25.ai to commercialize, or significant write-downs of the company's newly acquired intellectual property. High cash burn from diversification efforts could dilute shareholders further. Base CaseCentral scenario $0.7555% The base case assumes the core IVF business remains stable but flat, while the newly acquired divisions (NewGenProperty, NewGenDigital, and NewGenSup) face execution and regulatory hurdles. The K25.ai investment provides strategic exposure but does not immediately translate into significant operational cash flows, keeping the stock range-bound near its current levels. Bull CaseUpside scenario $1.5025% The bull case relies on the successful monetization of the K25.ai partnership, where NewGen holds exclusive APAC agency rights with capped commissions of up to US$5 million annually. If K25.ai's watch-to-predict platform gains rapid traction in Asia-Pacific and the company's digital asset treasury strategy yields high returns, the stock could experience a massive re-rating. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |